Biofrontera Inc.

NASDAQ: BFRI · Real-Time Price · USD
0.93
-0.04 (-3.73%)
At close: Aug 15, 2025, 9:52 AM

Biofrontera Income Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023 Q1 2023 Q4 2022 Q3 2022 Q2 2022 Q1 2022 Q4 2021 Q3 2021 Q2 2021 Q1 2021
Period Ending Jun 30, 2025 Mar 31, 2025 Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021
Revenue
9.03M 8.59M 12.55M 9.01M 7.84M 7.9M 10.6M 8.88M 5.85M 8.73M 10.14M 4.32M 4.46M 9.75M 9.17M 4.33M 5.86M 4.74M
Cost of Revenue
2.38M 3.08M 4.69M 4.88M 4.34M 3.95M 5.66M 4.5M 2.89M 4.6M 5.26M 2.23M 2.55M 5.15M 4.77M 2.29M 3.11M 2.57M
Gross Profit
6.65M 5.51M 7.86M 4.13M 3.5M 3.96M 4.93M 4.38M 2.96M 4.13M 4.89M 2.1M 1.9M 4.6M 4.39M 2.04M 2.75M 2.17M
Operating Income
-5.08M -4.55M -1.71M -4.96M -5.07M -5.47M -3.87M -4.62M -8.7M -5.69M -5.32M -5.84M -8.11M -3.11M -1.88M -16.11M -3.69M -3.53M
Interest Income
n/a 14K 15K 17K 24K 14K 21K 13K 42K 56K 57K 3K 54K 60K 3K 4K 4K 5K
Pretax Income
-5.3M -4.2M -1.4M -5.67M -237K -10.44M 3.52M -6.34M -9.82M -7.47M -2.78M -2.56M -850K 5.59M -14.5M -16.01M -3.62M -3.53M
Net Income
-5.32M -4.2M -1.4M -5.67M -257K -10.44M 3.53M -6.34M -9.84M -7.48M -2.79M -2.57M 7.07M 5.56M -14.51M -16.01M -3.66M -3.53M
Selling & General & Admin
10.53M 8.65M 8.17M 8.43M 7.95M 9.25M 9.06M 8.62M 11.55M 9.83M 10.21M 7.94M 10.02M 7.71M 9.28M 17.25M 5.75M 4.92M
Research & Development
870K 1.21M 782K 669K 621K 17K 33K 33K 11K n/a n/a n/a n/a n/a n/a n/a n/a n/a
Other Expenses
331K 200K 627K 1K n/a 166K n/a 369K 62K -33K 3K -22K 29K 23K n/a n/a n/a n/a
Operating Expenses
11.73M 10.06M 9.58M 9.1M 8.57M 9.43M 9.09M 9.02M 11.55M 9.83M 10.21M 7.94M 10.02M 7.71M 9.28M 17.25M 5.75M 4.92M
Interest Expense
-115K 120K 55K 9K 620K 1.42M 233K 155K 121K 91K 92K 92K 92K 93K 92K 90K 89K 89K
Selling & Marketing Expenses
n/a n/a n/a n/a n/a n/a n/a -74K n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Cost & Expenses
14.11M 13.13M 14.27M 13.97M 12.91M 13.38M 14.46M 13.52M 14.44M 14.43M 15.46M 10.16M 12.57M 12.86M 14.05M 19.54M 8.86M 7.49M
Income Tax Expense
21K -1K -2K 3K 20K 1K -6K 1K 14K 5K 1K 1K -7.92M 30K 5K 6K 44K 1K
Shares Outstanding (Basic)
9.35M 5.52M 5.52M 5.77M 5.09M 3.62M 2.14M 1.37M 1.36M 1.33M 1.33M 1.14M 941.17K 855.24K 560.04K 400K 397.93K 400K
Shares Outstanding (Diluted)
9.35M 5.52M 5.52M 5.77M 5.09M 3.62M 2.14M 1.37M 1.36M 1.33M 1.33M 1.14M 941.17K 856.66K 560.33K 400K 400K 400K
EPS (Basic)
-0.57 -0.76 2.97 -0.98 -0.05 -2.88 1.65 -4.64 -7.23 -5.6 -2.09 -2.26 7.51 6.50 -25.9 -40.03 -9.2 -8.84
EPS (Diluted)
-0.57 -0.76 2.97 -0.98 -0.05 -2.88 1.65 -4.64 -7.23 -5.6 -2.09 -2.26 7.51 6.49 -25.89 -40.03 -9.15 -8.84
EBITDA
-5.08M -4.55M -1.12M -5.34M 692K -8.71M 4.05M -5.93M -9.58M -7.25M -1.91M -2.34M -626K -2.98M -14.28M -15.78M -3.39M -3.31M
EBIT
n/a -4.08M -1.34M -5.66M 383K -9.02M 3.75M -6.19M -9.7M -7.38M -2.69M -2.47M -758K 5.68M -14.41M -15.92M -3.53M -3.44M
Depreciation & Amortization
n/a 219K 221K 312K 309K 307K 295K 251K 126K 127K 778K 131K 132K 131K 131K 134K 137K 138K